These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 12418493)

  • 1. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule.
    Bottiglieri T
    Am J Clin Nutr; 2002 Nov; 76(5):1151S-7S. PubMed ID: 12418493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.
    Hardy ML; Coulter I; Morton SC; Favreau J; Venuturupalli S; Chiappelli F; Rossi F; Orshansky G; Jungvig LK; Roth EA; Suttorp MJ; Shekelle P
    Evid Rep Technol Assess (Summ); 2003 Aug; (64):1-3. PubMed ID: 12899148
    [No Abstract]   [Full Text] [Related]  

  • 3. [S-adenosyl-L-methionine (SAMe) and its use in hepatology].
    Frezza M; Terpin MM; Peri A
    Minerva Gastroenterol Dietol; 1992; 38(3):145-51. PubMed ID: 1299337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropharmacology of S-adenosyl methionine.
    Carney MW
    Clin Neuropharmacol; 1986; 9(3):235-43. PubMed ID: 2424592
    [No Abstract]   [Full Text] [Related]  

  • 5. What is SAMe? S-Adenosylmethionine.
    Cowley G; Underwood A
    Newsweek; 1999 Jul; 134(1):46-50. PubMed ID: 10538206
    [No Abstract]   [Full Text] [Related]  

  • 6. S-adenosylmethionine (SAMe) therapy in liver disease: a review of current evidence and clinical utility.
    Anstee QM; Day CP
    J Hepatol; 2012 Nov; 57(5):1097-109. PubMed ID: 22659519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-adenosyl-L-methionine: its role in the treatment of liver disorders.
    Lieber CS
    Am J Clin Nutr; 2002 Nov; 76(5):1183S-7S. PubMed ID: 12418503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-Adenosylmethionine: molecular, biological, and clinical aspects--an introduction.
    Lieber CS; Packer L
    Am J Clin Nutr; 2002 Nov; 76(5):1148S-50S. PubMed ID: 12418492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuropsychiatric disorders and transmethylation: therapeutic effects of S-adenosyl-L-methionine].
    Agnoli A; Fazio C; Andreoli V; De Carolis V; Bonamini F; Pastorino P; Casacchia M; Cerbo R; Ruggieri S; Carolei A
    Clin Ter; 1975 Dec; 75(6):567-79. PubMed ID: 767041
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D
    Alcohol; 2002 Jul; 27(3):151-4. PubMed ID: 12163142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic indications of S-adenosyl methionine in neuropsychiatry].
    Tramoni AV; Azorin JM
    Encephale; 1988; 14(3):113-8. PubMed ID: 2900133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of S-adenosyl-L-methionine in the treatment of liver diseases.
    Lieber CS
    J Hepatol; 1999 Jun; 30(6):1155-9. PubMed ID: 10406198
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of S-adenosyl-L-methionine in liver health and injury.
    Mato JM; Lu SC
    Hepatology; 2007 May; 45(5):1306-12. PubMed ID: 17464973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolism pathways and use of heptral in chronic liver diseases].
    Il'chenko LIu; Vinnitskaia EV
    Eksp Klin Gastroenterol; 2002; (2):62-4, 103. PubMed ID: 12046390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of S-adenosyl l-methionine in a double-blinded, randomized, placebo-controlled, clinical trial for treatment of presumptive osteoarthritis in the dog.
    Imhoff DJ; Gordon-Evans WJ; Evans RB; Johnson AL; Griffon DJ; Swanson KS
    Vet Surg; 2011 Feb; 40(2):228-32. PubMed ID: 21244443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of exogenous S-adenosyl-L-methionine in patients with liver disease.
    Kaye GL; Blake JC; Burroughs AK
    Drugs; 1990; 40 Suppl 3():124-8. PubMed ID: 2081477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: S-adenosyl-L-methionine--a new therapeutic agent in liver disease?
    Osman E; Owen JS; Burroughs AK
    Aliment Pharmacol Ther; 1993 Feb; 7(1):21-8. PubMed ID: 8439634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Users say SAM-e is a wonder drug ... are they high?
    Boorstin J
    Fortune; 2000 Nov; 142(11):56. PubMed ID: 11186835
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethynylestradiol-induced impairment of bile secretion in the rat: protective effects of S-adenosyl-L-methionine and its implication in estrogen metabolism.
    Stramentinoli G; Di Padova C; Gualano M; Rovagnati P; Galli-Kienle M
    Gastroenterology; 1981 Jan; 80(1):154-8. PubMed ID: 7450400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemistry and pharmacology of S-adenosyl-L-methionine and rationale for its use in liver disease.
    Chawla RK; Bonkovsky HL; Galambos JT
    Drugs; 1990; 40 Suppl 3():98-110. PubMed ID: 2081485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.